News
Novo Nordisk's fling with Hims & Hers ends in a bust-up
The alliance between Novo Nordisk and telehealth firm Hims & Hers for the distribution of GLP-1 agonist weight-loss therapies has ended in acrimony.
Sales & Marketing
Sponsored
Company Profile: Medistry
With consumers struggling to differentiate between credible and unreliable medical information online, Medistry offers .med as a new, top level domain
News
EU kicks off review of GSK's linerixibat in PBC
GSK's drug for severe itching in patients with autoimmune liver disease PBC is now under review in the EU and US, as Mirum Pharma tries to catch up.
News
Madrigal closes on EU approval of first MASH treatment
Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.
News
Grail plans FDA filing for cancer blood test after new trial
Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
